Stay updated on SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial
Sign up to get notified when there's something new on the SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial page.

Latest updates to the SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page now displays the ClinicalTrials.gov record for the completed SAGE-718 Alzheimer’s disease study, with study design, participant criteria, outcomes, locations, and supporting documents.SummaryDifference64%

- Check16 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0 on the 403 error page.SummaryDifference0.2%

- Check23 days agoChange DetectedA sitewide notice announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology. The study record remains inaccessible behind a 403 error.SummaryDifference1%

- Check30 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2; the page still displays a 403 error.SummaryDifference0.2%

- Check37 days agoChange DetectedThe site revision identifier in the footer changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check58 days agoChange DetectedThe study page is presenting a 403 error instead of the full study record, making the core content inaccessible and leaving only the error screen visible.SummaryDifference18%

Stay in the know with updates to SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial page.